Biliary Atresia: Clinical Trials

75 trials for Biliary Atresia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

28 completed, 18 unknown, 17 recruiting, 4 not yet recruiting. 16 Not applicable, 10 Phase 2, 9 Phase 1, 6 Phase 3, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable16Completed 7, Recruiting 4, Unknown 3, Active not recruiting 1, Withdrawn 1
Phase 210Completed 5, Terminated 3, Recruiting 1, Unknown 1
Phase 19Completed 4, Recruiting 3, Not yet recruiting 2
Phase 36Active not recruiting 2, Completed 2, Terminated 1, Unknown 1
Phase 43Completed 2, Unknown 1
Early Phase 12Completed 1, Recruiting 1

Follow Biliary Atresia: new trials by email Literature Review of Biliary Atresia trials Research Report on Biliary Atresia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tolerability of Enteral NAC in Infants
N-Acetylcysteine - Biliary Atresia
Phase 1Not yet recruitingSanjiv Harpavat122026-10-012026-03-04
Umbilical Cord Mesenchymal Stem Cell Therapy for Biliary Atresia
Umbilical Cord-Mesenchymal Stem Cells (UC-MSC), Kasai Portoenterostomy - Biliary Atresia, Kasai Operation
Phase 1RecruitingDr Cipto Mangunkusumo General Hospital402026-09-012026-09-09
Dental Dyschromia and Quality of Life in Early Prolonged Hyperbilirubinemia
Questionnaires - Dental Diseases
RecruitingUniversity Hospital, Toulouse1202026-04-072026-05-12
The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis
Indocyanine Green - Biliary Atresia, Kasai
Early Phase 1RecruitingUniversity of Alabama at Birmingham152026-01-232026-02-18
Kasai Portoenterostomy Timing and Outcomes in Biliary Atresia
Kasai portoenterostomy - Biliary Atresia
CompletedThe Children's Hospital of Zhejiang University School of Medicine2002025-12-012026-02-06
Cholangitis Definition and Treatment After Kasai Hepatoportoenterostomy for Biliary Atresia: TRACK-BA Study (TRacking Cholangitis Post Kasai in Biliary Atresia)
Biliary Atresia, Kasai Portoenterostomy Status, Cholangitis
Not yet recruitingUniversity Hospital, Geneva402025-10-012025-08-19
Stool Card in Biliary Atresia
Stool Color Card, Biliary Atresia
Not yet recruitingAssiut University1002025-09-012025-08-24
Clinical Outcomes of Early Kasai Surgery With Umbilical Cord MSCs in Biliary Atresia
Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs), Kasai Portoenterostomy - Biliary Atresia, Kasai Portoenterostomy
Phase 1Not yet recruitingUniversitas Diponegoro142025-06-172025-06-08
The Dirty Nappy Study
Cholestasis in Newborn, Biliary Atresia
RecruitingBirmingham Women's and Children's NHS Foundation Trust53502025-04-012026-07-13
Nutritional Intervention for Biliary Atresia
high MCT formula, normal oral intake of the traditional formula - Nutrition Disorder, Infant, Biliary Atresia
Not applicableRecruitingTongji Hospital1202025-02-012025-12-22
Evaluation of the Use of Granulocyte Colony Stimulating Factor (GCSF) in Post Kasai Type 3 Biliary Atresia
Granulocyte Colony-Stimulating Factor - Granulocyte Colony-stimulating Factor, Biliary Atresia
Not applicableRecruitingNational Liver Institute, Egypt402024-12-012024-12-11
Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)
Maralixibat, Placebo - Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC)
Phase 3Active not recruitingMirum Pharmaceuticals, Inc.902024-10-142026-10-06
Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy
OCA, Matching Placebo - Biliary Atresia
Phase 2 / Phase 3TerminatedIntercept Pharmaceuticals282024-09-022026-07-07
Use of Indocyanine Green (ICG) for the Diagnosis of Biliary Atresia
Indocyanine Green (ICG) - Biliary Atresia
Phase 1 / Phase 2RecruitingBoston Children's Hospital202024-08-012026-04-06
ERAS in Choledochal Cyst & Biliary Atresia
Enhanced Recovery After Surgery, Post-operative care - Choledochal Cyst Resection, Biliary Atresia, Kasai Portoenterostomy Status
Not applicableRecruitingMuhammad Zubair Shoukat1002024-07-272026-07-16
Efficacy of New Post Kasai ILBS Protocol in Biliary Atresia.
Kasai Surgery - Biliary Atresia
UnknownInstitute of Liver and Biliary Sciences, India1002024-06-062024-06-11
Stem Cell Applications in Biliary Atresia Patients
Stem Cell, Control - Biliary Atresia, Fibrosis, Liver
Not applicableUnknownNecmi Kadıoğlu Hospital642024-06-012024-09-19
Biliary Atresia Research Network Northeast
Biliary Atresia
CompletedYale University3202024-05-062026-06-25
Robot-assisted Modified Kasai Portoenterostomy Versus Open Kasai Portoenterostomy for Biliary Atresia
robot-assisted modified Kasai portoenterostomy, traditional open Kasai portoenterostomy - Biliary Atresia, Kasai Operation
UnknownZunyi Medical College602023-12-212024-01-23
Intestinal Microbiome Composition in Infants With Biliary Atresia (BA)
Biliary Atresia, Intrahepatic Cholestases
WithdrawnChildren's Hospital Medical Center, Cincinnati2023-12-012025-07-09

Showing 20 of 75. Sign in to see all of them.

Narrower conditions

Cholangitis (8)  ·  Cholestasis (7)  ·  Liver Cirrhosis (6)  ·  Alagille Syndrome (4)  ·  Cholangitis, Sclerosing (4)  ·  Liver Cirrhosis, Biliary (4)  ·  Choledochal Cyst (2)  ·  Fibrosis (2)  ·  Hypertension, Portal (2)  ·  Rare Diseases (2)  ·  3-Methylglutaconic Aciduria, Type V (1)  ·  Achalasia Addisonianism Alacrimia syndrome (1)  ·  Acrodysostosis (1)  ·  Addison Disease (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (75)  ·  Digestive System Abnormalities (75)  ·  Bile Duct Diseases (74)  ·  Biliary Tract Diseases (74)  ·  Congenital Abnormalities (74)  ·  Digestive System Diseases (74)  ·  Liver Diseases (15)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  Pathologic Processes (12)  ·  Fibrosis (8)  ·  Cholestasis, Intrahepatic (7)  ·  Cholestasis (6)  ·  Cardiovascular Diseases (5)  ·  Abnormalities, Multiple (4)  ·  Cardiovascular Abnormalities (4)

Interventions

Portoenterostomy, Hepatic (6)  ·  Granulocyte Colony-Stimulating Factor (3)  ·  Acetylcysteine (2)  ·  Blood Specimen Collection (2)  ·  Filgrastim (2)  ·  Immunoglobulins, Intravenous (2)  ·  Indocyanine Green (2)  ·  Meropenem (2)  ·  Methylprednisolone (2)  ·  Prednisolone (2)  ·  Vancomycin (2)  ·  maralixibat (2)  ·  odevixibat (2)  ·  Adrenal Cortex Hormones (1)  ·  Anesthesia, General (1)

Sponsors

Children's Hospital of Fudan University (4)  ·  National Taiwan University Hospital (4)  ·  Arbor Research Collaborative for Health (3)  ·  Tongji Hospital (3)  ·  Vinmec Research Institute of Stem Cell and Gene Technology (3)  ·  Yonsei University (3)  ·  Albireo, an Ipsen Company (2)  ·  Baylor College of Medicine (2)  ·  Children's Hospital Medical Center, Cincinnati (2)  ·  Holterman, Ai-Xuan, M.D. (2)  ·  Institute of Liver and Biliary Sciences, India (2)  ·  Intercept Pharmaceuticals (2)  ·  Mirum Pharmaceuticals, Inc. (2)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2)  ·  Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (2)

Countries

United States (22)  ·  China (18)  ·  Canada (8)  ·  Germany (7)  ·  Taiwan (7)  ·  United Kingdom (7)  ·  France (6)  ·  Vietnam (6)  ·  Egypt (5)  ·  Poland (5)  ·  Turkey (Türkiye) (5)  ·  Australia (4)  ·  Italy (4)  ·  South Korea (4)  ·  Spain (4)

Top investigators

Ed Doo, MD (5)  ·  Averell Sherker, MD (3)  ·  John Magee, MD (3)  ·  Lisa Henn, PhD (3)  ·  Katrina Loh, MD (2)  ·  Liem Nguyen (2)  ·  Lynda Szczech, MD (2)  ·  Mei-Hwei Chang, MD (2)  ·  Ronald Sokol, MD (2)  ·  Avriana Pety Wardani, MD, Sp.BA (1)  ·  Benjamin Shneider, MD (1)  ·  Carsten R Engelmann, MD, OhD (1)  ·  Claus Petersen, Prof. (1)  ·  Danendra Rakha Putra Respati, MD (1)  ·  Erik Prabowo, Dr, MD, M.Si.Med, Sp.B-KBD (1)

Results publications

PMID 26725209, PMID 29519540, PMID 35391541, PMID 12183720, PMID 21475026, PMID 22732895, PMID 22891232, PMID 22903006, PMID 23054338, PMID 24244109, PMID 24493287, PMID 24794368, PMID 25015575, PMID 25419594, PMID 25534776, PMID 25564820, PMID 25681196, PMID 26756872, PMID 30244988, PMID 30488647, PMID 30664564, PMID 32633158, PMID 33664005, PMID 34310436, PMID 34817690, PMID 34842600, PMID 35207269, PMID 35287722, PMID 36602550, PMID 37471052, PMID 37678274, PMID 38055647, PMID 38189999, PMID 38994513, PMID 39526563, PMID 39568009, PMID 40250622, PMID 40489761, PMID 40907882, PMID 42165317

NIH funding

U01DK062456 (5), U01DK062436 (3), U01DK062445 (3), U01DK062452 (3), U01DK062453 (3), U01DK062466 (3), U01DK062470 (3), U01DK062481 (3), U01DK062497 (3), U01DK062500 (3), U01DK062503 (3), U01DK084536 (3), U01DK084538 (3), U01DK084575 (3), U01DK103135 (3)